➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
Moodys
Express Scripts
Boehringer Ingelheim

Last Updated: October 25, 2021

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-six branded drugs marketed by Abbvie, Sanofi Aventis Us, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Perrigo, Sun Pharm Inds Inc, and Rising, and is included in one hundred and thirty-one NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has seventy-five patent family members in twenty-six countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 2
Sorrento Therapeutics, Inc.Phase 2
Dow University of Health SciencesEarly Phase 1

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 087797-001 Jun 7, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ivax Pharms FLUTEX triamcinolone acetonide OINTMENT;TOPICAL 087375-001 Nov 1, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ivax Pharms TRIATEX triamcinolone acetonide CREAM;TOPICAL 087428-001 Nov 1, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Taro TRIAMCINOLONE ACETONIDE triamcinolone acetonide PASTE;DENTAL 070730-001 Oct 1, 1986 AT RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Novartis TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048-001 Nov 29, 2007 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ⤷  Try it Free ⤷  Try it Free
Novartis TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048-001 Nov 29, 2007 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.